Tag: PARP inhibitors

Triple-Negative Breast Cancer: Modern Treatment Strategies and Ongoing Clinical Trials

• Laura Ledas
• Dec, 21 2025

Triple-negative breast cancer (TNBC) is aggressive and hard to treat, but new therapies like immunotherapy, PARP inhibitors, and antibody-drug conjugates are improving outcomes. Learn about the latest treatment strategies and clinical trials changing the game in 2025.

Learn More